Letters in Drug Design & Discovery · 2012 · 10 citations · 14 references
Life SciencesMicrobiologyPharmacologyAntimicrobial ResistanceDrug DiscoveryMedical MicrobiologyAntibacterial AgentsAntibacterial PharmacologyMinimum Inhibitory Concentration DeterminationMinimum Inhibitory Concentration TestingMycobacterium Tuberculosis InfectionNovel Antibacterial Drug DiscoveryPhenotypic Drug Susceptibility TestingTuberculosis Drug DevelopmentTuberculosis Drug Resistance
14
A Diarylquinoline Drug Active on the ATP Synthase of <i>Mycobacterium tuberculosis</i>
Koen Andries, Peter Verhasselt, Jérôme Guillemont et al. · Science · 2004 · 2.2K citations · Full text
The Diarylquinoline TMC207 for Multidrug-Resistant Tuberculosis
Andreas H. Diacon, Alexander S. Pym, Martin P. Grobusch et al. · New England Journal of Medicine · 2009 · 839 citations · Full text
James M. Rae, Michael D. Johnson, Marc E. Lippman et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 303 citations
Medicine, Biochemistry, Pharmacology +17